These data suggest mechanisms that potentially explain why previous anti-TNF strategies targeting soluble TNF have shown little benefit for acute inflammatory diseases such as sepsis or acute respiratory distress syndrome (ARDS) (18). Here, TNF is linked to acute respiratory distress syndrome.